This shows you the differences between two versions of the page.
Both sides previous revision Previous revision Next revision | Previous revision | ||
research:characterization_of_oral_antibiotics_for_acne_treatment [2020/03/23 17:32] crundle |
research:characterization_of_oral_antibiotics_for_acne_treatment [2020/03/25 15:51] (current) schillil |
||
---|---|---|---|
Line 2: | Line 2: | ||
**Objective:** | **Objective:** | ||
- | To characterize the international distribution of oral antibiotic use, specifically antibiotic type and duration, for acne in two age groups: youth (ages 12 to 20) and adults (ages 21 to 40). | + | 1. Describe the prevalence of systemic antibiotic treatment for acne by age and gender and to compare how systemic antibiotic prevalence for acne varies by country. |
+ | 2. Describe the prevalence of systemic isotretinoin treatment for acne by age and gender and to compare how systemic isotretinoin prevalence for acne varies by country. | ||
+ | 3. Characterize systemic antibiotic use for acne by type, dose, course duration, number of courses, and pathway course (which antibiotic started first) by age and gender and to compare how this use varies by country. | ||
+ | 4. Characterize systemic isotretinoin use for acne by dose, course duration, number of courses by age and gender and to compare how this use varies by country. | ||
+ | 5. Examine the frequency and duration of antibiotic use prior to isotretinoin prescribing (ie How long course of antibiotics before a patient is switched to isotretinoin) varies by data source and country. | ||
Line 26: | Line 30: | ||
[[https://docs.google.com/document/d/1LnugUQrloOn-3cZJDdTpgVYEsynu7SBztFtjzjAuEDE/edit?usp=sharing]] | [[https://docs.google.com/document/d/1LnugUQrloOn-3cZJDdTpgVYEsynu7SBztFtjzjAuEDE/edit?usp=sharing]] | ||
- | **Initial Proposal Date:** //25 August 2016// | + | **Initial Proposal Date:** //01 January 2020// |
**Launch Date:** // // | **Launch Date:** // // |